These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 12607150)
41. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Diamond BJ; Johnson SK; Kaufman M; Graves L Arch Clin Neuropsychol; 2008 Mar; 23(2):189-99. PubMed ID: 18053682 [TBL] [Abstract][Full Text] [Related]
43. Regression-based norms improve the sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS). Smerbeck AM; Parrish J; Yeh EA; Weinstock-Guttman B; Hoogs M; Serafin D; Krupp L; Benedict RH Clin Neuropsychol; 2012; 26(6):985-1002. PubMed ID: 22849345 [TBL] [Abstract][Full Text] [Related]
44. Cognitive impairment and decline in different MS subtypes. Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951 [TBL] [Abstract][Full Text] [Related]
45. Sex differences in cognitive impairment in multiple sclerosis. Beatty WW; Aupperle RL Clin Neuropsychol; 2002 Dec; 16(4):472-80. PubMed ID: 12822056 [TBL] [Abstract][Full Text] [Related]
46. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis. Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887 [TBL] [Abstract][Full Text] [Related]
53. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356 [TBL] [Abstract][Full Text] [Related]
54. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Daly E; Komaroff AL; Bloomingdale K; Wilson S; Albert MS Appl Neuropsychol; 2001; 8(1):12-22. PubMed ID: 11388119 [TBL] [Abstract][Full Text] [Related]
55. [Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study]. Zéphir H; de Sèze J; Dujardin K; Dubois G; Cabaret M; Bouillaguet S; Ferriby D; Stojkovic T; Vermersch P Rev Neurol (Paris); 2008 Jan; 164(1):47-52. PubMed ID: 18342057 [TBL] [Abstract][Full Text] [Related]
56. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Arnett PA; Higginson CI; Voss WD; Randolph JJ; Grandey AA Clin Neuropsychol; 2002 Aug; 16(3):341-55. PubMed ID: 12607147 [TBL] [Abstract][Full Text] [Related]
57. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables]. Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054 [TBL] [Abstract][Full Text] [Related]
58. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ruet A; Brochet B Ann Phys Rehabil Med; 2020 Mar; 63(2):154-158. PubMed ID: 29462665 [TBL] [Abstract][Full Text] [Related]
59. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275 [TBL] [Abstract][Full Text] [Related]
60. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]